ADMA Biologics, Inc. (ADMA)

19.54 +0.05 (+0.26%) USD  |  NASDAQ  |  Dec 24, 16:00
More

ADMA Biologics Proceeds from Stock Option Exercised (Quarterly)

Proceeds from Stock Option Exercised (Quarterly) Chart

View Proceeds from Stock Option Exercised (Quarterly) for ADMA.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Proceeds from Stock Option Exercised (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Proceeds from Stock Option Exercised (Quarterly) Range, Past 5 Years

View Proceeds from Stock Option Exercised (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Proceeds from Stock Option Exercised (Quarterly) Benchmarks

View Proceeds from Stock Option Exercised (Quarterly) Benchmarks
Start Trial
ACADIA Pharmaceuticals, Inc. Upgrade
Vanda Pharmaceuticals, Inc. Upgrade
Aldeyra Therapeutics, Inc. Upgrade
Arcutis Biotherapeutics, Inc. Upgrade
Exelixis, Inc. Upgrade